Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Hospira submits biologics application to FDA for proposed epoetin alfa biosimilar

News of their application comes less than a week after the FDA's Oncologic Drugs Advisory Committee unanimously recommended the approval of Sandoz' biosimilar.

Hospira submitted a biologics license application to the FDA for Retacrit, a proposed biosimilar to Amgen's EPOGEN (epoetin alfa) and Janssen's PROCRIT.

According to a company-issued press release this week, the application was submitted on Dec. 16, 2014, under the new 351(k) approval pathway created by the Biologics Price Competition and Innovation Act of 2009.

News of their application comes less than a week after the FDA's Oncologic Drugs Advisory Committee unanimously recommended the approval of Sandoz' biosimilar that is comparable to Amgen's Neupogen. It signaled being one step closer to the U.S. approving their biosimilar.

"As one of the first companies to submit a biosimilar application in the United States, we are proud to be a leader who can help our country's healthcare system decrease unsustainable costs by embracing a new frontier in medicine," said Sumant Ramachandra, M.D., Ph.D., Senior Vice President, Chief Scientific Officer, Hospira."Hospira is proud to build upon our global experience of providing biosimilars to patients across the world."

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report